ABB recently opened its first global healthcare research hub on the Texas Medical Center (TMC) campus, in Houston, Texas – showcasing a number of concept technologies, including a mobile YuMi® robot, which will be designed to assist medical and laboratory staff with laboratory and logistics tasks in hospitals
NAMSA, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated testing, clinical research, reimbursement and regulatory consulting services, is pleased to announce that it has been awarded DIN EN ISO/IEC 17025:2018 accreditation by DAkkS
Biodesix, Inc., recently announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD)
Foundation Medicine, Inc. and Natera, Inc. recenty announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical and clinical customers who order FoundationOne CDx
SCIEX, a global leader in life science analytical technologies, announced recently that a suite of medical devices has been approved by ANVISA, the Brazilian Health Regulatory Agency, for meeting the market access requirements for medical device products
Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs
Lung cancer is the most common cancer worldwide, accounting for 2.1 million new cases and 1.8 million deaths in 2018
MOBILion Systems, Inc. is partnering with Agilent Technologies Inc. to integrate its patented ion mobility separations technology, called Structures for Lossless Ion Manipulation (SLIM), with Agilent’s Q-TOF mass spectrometry platform as the company’s first commercial product offering
Nano Discovery Inc. announced recently that it has launched a new blood test to the market for cattle immune health testing. Cattle owners and veterinary practitioners can order this test by submitting blood samples to Nano Discovery’s central laboratory, or conduct this test in their local farms and clinics by purchasing testing kits from the company
Charles River Laboratories International, Inc. recently announced the launch of two new products in its Microbial Solutions portfolio: an updated EndoScan-V software platform for endotoxin detection and measurement; and the introduction of the Celsis automated detection solution for rapid sterility to ensure continued product quality and contamination control for pharmaceutical manufacturing clients
|
|
|
|
|
|
|
|
|